SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?


To: oilbabe who wrote (74378)1/24/2000 6:07:00 PM
From: Knighty Tin  Respond to of 132070
 
Oilbabe, You are right. I hold a full position on Vaso. I got info on this company from a broker friend and then read more about how they were saving lives in, of all places, "The National Enquirer." Their technique, inflating and deflating pressure cuffs in strategic locations around the body looks so silly it is hard to believe. But it works and is one of the best and certainly the least invasive ways to assure survival during heart surgery.

They received HCFA reimbursement authorization nationwide last quarter, which quickly boosted revenues and allowed them to earn a tiny profit. However, few doctors know about the procedure's benefit, so the potential is to the moon, IMHO.

The stock came under severe pressure last year because it was touted by a guy accused of stock fraud. However, he had nothing to do with the co. and simply oversold the story too soon. Not Vaso's fault, but the stock did suffer. Which provided buying opportunities under $1 a share, which yours truly took advantage of, after an initial purchase of a third at 1 7/8. I think at 2 and change that it is still a bargain.

They just changed CEOs. The guy who left was more on the scientific side and the new guy is more of a business developer. I think both were the right guys at the right time.

However, this is a very speculative stock and you shouldn't bet the ranch on it. I like it, but it is not Merck.